Rociletinib (CO-1686) enhanced the efficacy of chemotherapeutic agents in ABCG2-overexpressing cancer cells in vitro and in vivo

Overexpression of adenosine triphosphate (ATP)-binding cassette subfamily G member 2 (ABCG2) in cancer cells is known to cause multidrug resistance (MDR), which severely limits the clinical efficacy of chemotherapy. Currently, there is no FDA-approved MDR modulator for clinical use. In this study, r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Acta Pharm Sin B
Main Authors: Zeng, Fanpu, Wang, Fang, Zheng, Zongheng, Chen, Zhen, Wah To, Kenneth Kin, Zhang, Hong, Han, Qian, Fu, Liwu
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2020
Assuntos:
Original article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7280144/
https://ncbi.nlm.nih.gov/pubmed/32528828
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.apsb.2020.01.008
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados